CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Validation of Biomarkers Determining Resistance to BTK Inhibition With Ibrutinib in Mantle Cell Lymphoma & Chronic Lymphocytic Leukaemia - Stage 1

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02267590
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:49.986798+00:00
Published At: 2014-10-17T00:00:00+00:00
Record Updated At: 2014-10-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Mantle Cell Lymphoma", "Chronic Lymphocytic Leukaemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-10-17"
protocolSection.identificationModule.nctId: "NCT02267590"
protocolSection.identificationModule.officialTitle: "Clinical Validation of Biomarkers Determining Resistance to BTK Inhibition With Ibrutinib in Mantle Cell Lymphoma \u0026 Chronic Lymphocytic Leukaemia - Stage 1"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.